• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-糖基化修饰调控转铁蛋白受体(TFRC)的稳定性,从而控制肝癌细胞中的铁死亡。

O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells.

机构信息

School of Life Sciences, Sichuan University, Chengdu, 610041, China.

State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.

出版信息

Redox Biol. 2024 Jul;73:103182. doi: 10.1016/j.redox.2024.103182. Epub 2024 May 8.

DOI:10.1016/j.redox.2024.103182
PMID:38744192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11103954/
Abstract

Ferroptosis is an iron-dependent programmed cell death (PCD) enforced by lipid peroxidation accumulation. Transferrin receptor (TFRC), one of the signature proteins of ferroptosis, is abundantly expressed in hepatocellular carcinoma (HCC). However, post-translational modification (PTM) of TFRC and the underlying mechanisms for ferroptosis regulation remain less understood. In this study, we found that TFRC undergoes O-GlcNAcylation, influencing Erastin-induced ferroptosis sensitivity in hepatocytes. Further mechanistic studies found that Erastin can trigger de-O-GlcNAcylation of TFRC at serine 687 (Ser687), which diminishes the binding of ubiquitin E3 ligase membrane-associated RING-CH8 (MARCH8) and decreases polyubiquitination on lysine 665 (Lys665), thereby enhancing TFRC stability that favors labile iron accumulation. Therefore, our findings report O-GlcNAcylation on an important regulatory protein of ferroptosis and reveal an intriguing mechanism by which HCC ferroptosis is controlled by an iron metabolism pathway.

摘要

铁死亡是一种由脂质过氧化积累引起的铁依赖性程序性细胞死亡(PCD)。转铁蛋白受体(TFRC)是铁死亡的标志性蛋白之一,在肝细胞癌(HCC)中大量表达。然而,TFRC 的翻译后修饰(PTM)和铁死亡调控的潜在机制仍知之甚少。在这项研究中,我们发现 TFRC 发生 O-GlcNAcylation,影响 Erastin 诱导的肝细胞铁死亡敏感性。进一步的机制研究发现,Erastin 可以触发 TFRC 在丝氨酸 687(Ser687)处去 O-GlcNAcylation,从而减少泛素 E3 连接酶膜相关环指蛋白 8(MARCH8)与赖氨酸 665(Lys665)的结合,减少赖氨酸 665(Lys665)上的多泛素化,从而增强 TFRC 的稳定性,有利于不稳定铁的积累。因此,我们的研究结果报道了铁死亡重要调节蛋白的 O-GlcNAcylation,并揭示了 HCC 铁死亡受铁代谢途径调控的一种有趣机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/5a59df52efd1/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/198aecb4c204/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/354e3ffdfda7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/ca797a89121d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/50d09958e045/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/54af1315796b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/671dac900af8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/31fc17dd21d6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/5a59df52efd1/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/198aecb4c204/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/354e3ffdfda7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/ca797a89121d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/50d09958e045/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/54af1315796b/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/671dac900af8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/31fc17dd21d6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c62e/11103954/5a59df52efd1/gr7.jpg

相似文献

1
O-GlcNAcylation regulates the stability of transferrin receptor (TFRC) to control the ferroptosis in hepatocellular carcinoma cells.O-糖基化修饰调控转铁蛋白受体(TFRC)的稳定性,从而控制肝癌细胞中的铁死亡。
Redox Biol. 2024 Jul;73:103182. doi: 10.1016/j.redox.2024.103182. Epub 2024 May 8.
2
CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis.CCT3/ACTN4/TFRC 轴通过抑制铁内吞作用来保护肝癌细胞免受铁死亡。
J Exp Clin Cancer Res. 2024 Aug 29;43(1):245. doi: 10.1186/s13046-024-03169-7.
3
TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis.TRIM33 通过增强 TFRC 的泛素化来增强肝癌细胞对铁死亡的易感性。
Cell Signal. 2024 Sep;121:111268. doi: 10.1016/j.cellsig.2024.111268. Epub 2024 Jun 21.
4
Ceruloplasmin suppresses ferroptosis by regulating iron homeostasis in hepatocellular carcinoma cells.铜蓝蛋白通过调节肝癌细胞中的铁稳态来抑制铁死亡。
Cell Signal. 2020 Aug;72:109633. doi: 10.1016/j.cellsig.2020.109633. Epub 2020 Apr 10.
5
O-GlcNAcylation enhances sensitivity to RSL3-induced ferroptosis via the YAP/TFRC pathway in liver cancer.O-连接的N-乙酰葡糖胺化通过YAP/转铁蛋白受体途径增强肝癌细胞对RSL3诱导的铁死亡的敏感性。
Cell Death Discov. 2021 Apr 16;7(1):83. doi: 10.1038/s41420-021-00468-2.
6
O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity.O-GlcNAcylation 通过调控 FOXA2 的稳定性和转录活性促进肝癌细胞的迁移能力。
J Cell Physiol. 2021 Nov;236(11):7491-7503. doi: 10.1002/jcp.30385. Epub 2021 Apr 12.
7
MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis.微小RNA-152介导的肝脏致癌过程中肝转铁蛋白受体1的失调
Oncotarget. 2016 Jan 12;7(2):1276-87. doi: 10.18632/oncotarget.6004.
8
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway.转铁蛋白受体 1 通过激活 mTOR 信号通路促进肝癌的进展和转移。
Hepatol Int. 2024 Apr;18(2):636-650. doi: 10.1007/s12072-023-10607-9. Epub 2023 Nov 20.
9
Expression of transferrin receptor/TFRC protein in bladder cancer cell T24 and its role in inducing iron death in bladder cancer.转铁蛋白受体/TFRC 蛋白在膀胱癌 T24 细胞中的表达及其诱导膀胱癌铁死亡的作用。
Int J Biol Macromol. 2024 Aug;274(Pt 1):133323. doi: 10.1016/j.ijbiomac.2024.133323. Epub 2024 Jun 20.
10
E3 ubiquitin ligase CHIP interacts with transferrin receptor 1 for degradation and promotes cell proliferation through inhibiting ferroptosis in hepatocellular carcinoma.E3 泛素连接酶 CHIP 与转铁蛋白受体 1 相互作用促进其降解,并通过抑制肝细胞癌中的铁死亡来促进细胞增殖。
Cell Signal. 2024 Jun;118:111148. doi: 10.1016/j.cellsig.2024.111148. Epub 2024 Mar 21.

引用本文的文献

1
Potential therapeutic target in oncology: Protein palmitoylation (Review).肿瘤学中的潜在治疗靶点:蛋白质棕榈酰化(综述)
Oncol Rep. 2025 Oct;54(4). doi: 10.3892/or.2025.8950. Epub 2025 Jul 19.
2
Silencing NEDD4L Effectively Inhibits the Malignant Behaviors of Hepatocellular Carcinoma.沉默NEDD4L可有效抑制肝癌的恶性行为。
J Hepatocell Carcinoma. 2025 Jul 10;12:1369-1391. doi: 10.2147/JHC.S511466. eCollection 2025.
3
Oxidative Stress and Inflammation: Drivers of Tumorigenesis and Therapeutic Opportunities.氧化应激与炎症:肿瘤发生的驱动因素及治疗机遇
Antioxidants (Basel). 2025 Jun 15;14(6):735. doi: 10.3390/antiox14060735.
4
Linoleic acid metabolite 13-Hydroxyoctadecadienoic acid as a biphasic ferroptosis modulator in granulosa cells: multi-omics analysis of ovine atretic follicles.亚油酸代谢物13-羟基十八碳二烯酸作为颗粒细胞中双相铁死亡调节剂:绵羊闭锁卵泡的多组学分析
Front Cell Dev Biol. 2025 May 30;13:1610621. doi: 10.3389/fcell.2025.1610621. eCollection 2025.
5
The TFRC as a prognostic biomarker and potential therapeutic target in cervical cancer: a preliminary study.作为宫颈癌预后生物标志物和潜在治疗靶点的TFRC:一项初步研究。
Front Oncol. 2025 Apr 15;15:1523137. doi: 10.3389/fonc.2025.1523137. eCollection 2025.
6
Ferroptosis and hyperoxic lung injury: insights into pathophysiology and treatment approaches.铁死亡与高氧性肺损伤:对病理生理学及治疗方法的见解
Front Pharmacol. 2025 Mar 18;16:1568246. doi: 10.3389/fphar.2025.1568246. eCollection 2025.
7
WBP1 regulates mitochondrial function and ferroptosis to modulate chemoresistance in colorectal cancer.WBP1通过调节线粒体功能和铁死亡来调控结直肠癌的化疗耐药性。
Mol Med. 2025 Mar 12;31(1):93. doi: 10.1186/s10020-025-01151-3.
8
O-GlcNAcylation attenuates ischemia-reperfusion-induced pulmonary epithelial cell ferroptosis via the Nrf2/G6PDH pathway.O-连接的N-乙酰葡糖胺糖基化通过Nrf2/G6PDH途径减轻缺血再灌注诱导的肺上皮细胞铁死亡。
BMC Biol. 2025 Feb 4;23(1):32. doi: 10.1186/s12915-025-02126-w.
9
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy.靶向细胞死亡机制:自噬和铁死亡在肝细胞癌治疗中的潜力。
Front Immunol. 2024 Sep 9;15:1450487. doi: 10.3389/fimmu.2024.1450487. eCollection 2024.
10
Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma.解析 O-糖基化在肝细胞癌中的作用。
Biomolecules. 2024 Jul 25;14(8):908. doi: 10.3390/biom14080908.